BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
금요일, 9월 25

Senti Biosciences Holdings Inc

SNTINASDAQ
Trade with Public
Trade with Public
$0.3430
가까이에: Sep 25, 5:00 PM EST
$0.3100
-0.033-9.62%
시간외: 7:59 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교주식 보고서

Senti Biosciences Earnings & Forecasts

Senti Biosciences (SNTI) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

Senti Biosciences Guidance

Recent Earnings Results

MetricQ2 '26Q1 '26Q4 '25Q3 '25
Earnings Per Share (Non-GAAP)
Estimate$-0.28$-0.34$-0.46$-0.58
Actual$-0.41$-0.14$-0.53$-0.69
Surprise-46.4%+58.8%-15.2%-19.0%
Revenue
Estimate——$500000$166670
Actual$17000$16000$22000$0
Surprise——-95.6%-100.0%
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
MetricQ3 '26EQ4 '26E
Earnings Per Share (Non-GAAP)
Consensus$-0.31$-0.35
Revenue
Consensus——
More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
Senti Biosciences Q1 EPS $(0.14) Beats $(0.36) Estimate, Sales $16.000K

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.36) by 61.11 percent. This is a 90.07 percent increase over losses of $(1.41) per share from
Benzinga Newsdesk

PRO
Senti Biosciences Q4 EPS $(0.53) Misses $(0.48) Estimate, Sales $22.000K Miss $666.667K Estimate

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.48) by 11.11 percent. This is a 20.9 percent increase over losses of $(0.67) per share
Benzinga Newsdesk

PRO
Senti Biosciences Q3 EPS $(0.69) Misses $(0.56) Estimate

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.56) by 23.21 percent. This is a 89.06 percent increase over losses of $(6.31) per share
Benzinga Newsdesk

PRO
Senti Biosciences Q2 EPS $(0.56) Beats $(0.90) Estimate

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.90) by 37.78 percent. This is a 77.14 percent increase over losses of $(2.45) per share from
Benzinga Newsdesk

PRO
Senti Biosciences Q1 EPS $(1.41) Up From $(2.60) YoY

Benzinga Newsdesk

PRO
Senti Bio Sciences Q4 EPS ($0.67) Up From ($4.19) YoY.

Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved